Short-term fibronectin treatment induces endothelial-like and angiogenic properties in monocyte-derived immature dendritic cells: Involvement of intracellular VEGF and MAPK regulation

European Journal of Cell Biology

Volumn 91, Issue 8, 2012, Pages 640-653

  Berger, Slava ^a   Dyugovskaya, Larissa ^a   Polyakov, Andrey ^a   Lavie, Lena ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Angiogenesis; Dendritic cells; ERK1 2; Fibronectin; Intracrine and paracrine regulation; Laminin; Mitochondria; P38MAPK; Phagocytosis; VEGF

Indexed keywords

FIBRONECTIN; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; THROMBOMODULIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL STRUCTURE; CONFOCAL MICROSCOPY; DENDRITIC CELL; ENDOTHELIUM; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MONOCYTE; NORMAL HUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADULT; ANTIGENS, CD1; BUTADIENES; CELL SHAPE; CULTURE MEDIA, CONDITIONED; DENDRITIC CELLS; ENDOTHELIAL CELLS; FIBRONECTINS; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMIDAZOLES; LEUKOCYTES, MONONUCLEAR; MALE; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; NITRILES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PHENOTYPE; PHOSPHORYLATION; PYRIDINES; THROMBOMODULIN; TIME FACTORS; TIME-LAPSE IMAGING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

ULEX EUROPAEUS;

EID: 84861695519     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2012.02.003     Document Type: Article

References (70)

1. Arce F., Breckpot K., Stephenson H., Karwacz K., Ehrenstein M.R., Collins M., Escors D. Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis. Arthritis Rheum. 2011, 63:84-95.
2. Ardeshna K.M., Pizzey A.R., Devereux S., Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000, 96:1039-1046.
3. Arrighi J.F., Rebsamen M., Rousset F., Kindler V., Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J. Immunol. 2001, 166:3837-3845.
4. Asakage M., Tsuno N.H., Kitayama J., Kawai K., Okaji Y., Yazawa K., Kaisaki S., Osada T., Watanabe T., Takahashi K., Nagawa H. Early-outgrowth of endothelial progenitor cells can function as antigen-presenting cells. Cancer Immunol. Immunother. 2006, 55:708-716.
5. Bauer J., Margolis M., Schreiner C., Edgell C.J., Azizkhan J., Lazarowski E., Juliano R.L. In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins. J. Cell Physiol. 1992, 153:437-449.
6. Bertolino P., Deckers M., Lebrin F., ten Dijke P. Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 2005, 128:585S-590S.
7. Bobryshev Y.V., Lord R.S. Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and athero-prone areas of the normal aorta. Arch. Histol. Cytol. 1995, 58:307-322.
8. Bobryshev Y.V., Lord R.S. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc. Res. 1998, 37:799-810.
9. Brand U., Bellinghausen I., Enk A.H., Jonuleit H., Becker D., Knop J., Saloga J. Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur. J. Immunol. 1998, 28:1673-1680.
10. Cheng A., Hou Y., Mattson M.P. Mitochondria and neuroplasticity. ASN Neuro. 2010, 2:243-256.
11. Choi J.H., Do Y., Cheong C., Koh H., Boscardin S.B., Oh Y.S., Bozzacco L., Trumpfheller C., Park C.G., Steinman R.M. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 2009, 206:497-505.
12. Cybulsky M.I., Jongstra-Bilen J. Resident intimal dendritic cells and the initiation of atherosclerosis. Curr. Opin. Lipidol. 2010, 21:397-403.
13. David Dong Z.M., Aplin A.C., Nicosia R.F. Regulation of angiogenesis by macrophages, dendritic cells, and circulating myelomonocytic cells. Curr. Pharm. Des. 2009, 15:365-379.
14. Del Prete A., Zaccagnino P., Di Paola M., Saltarella M., Oliveros Celis C., Nico B., Santoro G., Lorusso M. Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radical Biol. Med. 2008, 44:1443-1451.
15. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U.S.A. 1983, 80:3734-3737.
16. Elkord E., Williams P.E., Kynaston H., Rowbottom A.W. Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology 2005, 114:204-212.
17. Fainaru O., Almog N., Wing Yung C., Nakai K., Montoya-Zavala M., Abollahi A., D'Amato R., Ingber D.E. Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells. FASEB J. 2009, 24:1411-1418.
18. Fernandez Pujol B., Lucibello F.C., Zuzarte M., Lutjens P., Muller R., Havemann K. Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. Eur. J. Cell Biol. 2001, 80:99-110.
19. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
20. Ferrara N., Hillan K.J., Novotny W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem. Biophys. Res. Commun. 2005, 333:328-335.
21. Garcia-Nieto S., Johal R.K., Shakesheff K.M., Emara M., Royer P.J., Chau D.Y., Shakib F., Ghaemmaghami A.M. Laminin and fibronectin treatment leads to generation of dendritic cells with superior endocytic capacity. PLoS One 2010, 5:e10123.
22. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002, 20:621-667.
23. Gulati R., Jevremovic D., Peterson T.E., Chatterjee S., Shah V., Vile R.G., Simari R.D. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 2003, 93:1023-1025.
24. Havemann K., Pujol B.F., Adamkiewicz J. In vitro transformation of monocytes and dendritic cells into endothelial like cells. Adv. Exp. Med. Biol. 2003, 522:47-57.
25. Hiasa M., Abe M., Nakano A., Oda A., Amou H., Kido S., Takeuchi K., Kagawa K., Yata K., Hashimoto T., Ozaki S., Asaoka K., Tanaka E., Moriyama K., Matsumoto T. GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE). Blood 2009, 114:4517-4526.
26. Hirashima M. Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling. Anatom. Sci. Int. 2009, 84:95-101.
27. Jan M.S., Huang Y.H., Shieh B., Teng R.H., Yan Y.P., Lee Y.T., Liao K.K., Li C. CC chemokines induce neutrophils to chemotaxis, degranulation, and alpha-defensin release. J. Acquir. Immune Defic. Syndr. 2006, 41:6-16.
28. Jancic C., Chuluyan H.E., Morelli A., Larregina A., Kolkowski E., Saracco M., Barboza M., Leiva W.S., Fainboim L. Interactions of dendritic cells with fibronectin and endothelial cells. Immunology 1998, 95:283-290.
29. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., Li T., Isner J.M., Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:3422-3427.
30. Kohl K., Schnautz S., Pesch M., Klein E., Aumailley M., Bieber T., Koch S. Subpopulations of human dendritic cells display a distinct phenotype and bind differentially to proteins of the extracellular matrix. Eur. J. Cell Biol. 2007, 86:719-730.
31. Kvistborg P., Boegh M., Pedersen A.W., Claesson M.H., Zocca M.B. Fast generation of dendritic cells. Cell Immunol. 2009, 260:56-62.
32. Lehtonen A., Ahlfors H., Veckman V., Miettinen M., Lahesmaa R., Julkunen I. Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J. Leukoc. Biol. 2007, 82:710-720.
33. Lejbkowicz F., Goldberg-Cohen I., Levy A.P. New horizons for VEGF. Is there a role for nuclear localization?. Acta Histochem. 2005, 106:405-411.
34. Li W., Keller G. VEGF nuclear accumulation correlates with phenotypical changes in endothelial cells. J. Cell Sci. 2000, 113(Pt 9):1525-1534.
35. Li Y.H., Shi G.Y., Wu H.L. The role of thrombomodulin in atherosclerosis: from bench to bedside. Cardiovasc. Hematol. Agents Med. Chem. 2006, 4:183-187.
36. Lu J., Zhao J., Liu K., Yang H., Huang Y., Qin Z., Bai R., Li P., Ma J., Yan W., Zhao M., Dong Z. MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma. Cell Mol. Life Sci. 2010, 67:2091-2106.
37. Lu J., Zhao J., Ma J., Liu K., Yang H., Huang Y., Qin Z., Bai R., Li P., Yan W., Zhao M., Dong Z. VEGF-A-induced immature DCs not mature DCs differentiation into endothelial-like cells through ERK1/2-dependent pathway. Cell Biochem. Function 2011, 29:294-302.
38. Luo X., Liu L., Tang N., Lu K.Q., McCormick T.S., Kang K., Cooper K.D. Inhibition of monocyte-derived dendritic cell differentiation and interleukin-12 production by complement iC3b via a mitogen-activated protein kinase signalling pathway. Exp. Dermatol. 2005, 14:303-310.
39. Matos T.J., Duarte C.B., Goncalo M., Lopes M.C. Role of oxidative stress in ERK and p38 MAPK activation induced by the chemical sensitizer DNFB in a fetal skin dendritic cell line. Immunol. Cell Biol. 2005, 83:607-614.
40. Maurer L.M., Tomasini-Johansson B.R., Mosher D.F. Emerging roles of fibronectin in thrombosis. Thromb. Res. 2010, 125:287-291.
41. Mina-Osorio P., Winnicka B., O'Conor C., Grant C.L., Vogel L.K., Rodriguez-Pinto D., Holmes K.V., Ortega E., Shapiro L.H. CD13 is a novel mediator of monocytic/endothelial cell adhesion. J. Leukoc. Biol. 2008, 84:448-459.
42. Mukai N., Akahori T., Komaki M., Li Q., Kanayasu-Toyoda T., Ishii-Watabe A., Kobayashi A., Yamaguchi T., Abe M., Amagasa T., Morita I. A comparison of the tube forming potentials of early and late endothelial progenitor cells. Exp. Cell Res. 2008, 314:430-440.
43. Mukdsi J.H., De Paul A.L., Gutierrez S., Roth F.D., Aoki A., Torres A.I. Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas. J. Mol. Histol. 2005, 36:447-454.
44. Nakahara T., Moroi Y., Uchi H., Furue M. Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J. Dermatol. Sci. 2006, 42:1-11.
45. Orr A.W., Sanders J.M., Bevard M., Coleman E., Sarembock I.J., Schwartz M.A. The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. J. Cell Biol. 2005, 169:191-202.
46. Oyama T., Ran S., Ishida T., Nadaf S., Kerr L., Carbone D.P., Gabrilovich D.I. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J. Immunol. 1998, 160:1224-1232.
47. Perrin-Cocon L., Coutant F., Agaugue S., Deforges S., Andre P., Lotteau V. Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J. Immunol. 2001, 167:3785-3791.
48. Pietschmann P., Stockl J., Draxler S., Majdic O., Knapp W. Functional and phenotypic characteristics of dendritic cells generated in human plasma supplemented medium. Scand. J. Immunol. 2000, 51:377-383.
49. Puig-Kroger A., Relloso M., Fernandez-Capetillo O., Zubiaga A., Silva A., Bernabeu C., Corbi A.L. Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 2001, 98:2175-2182.
50. Re R.N., Cook J.L. An intracrine view of angiogenesis. Bioessays 2006, 28:943-953.
51. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood " endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
52. Relloso M., Puig-Kroger A., Pello O.M., Rodriguez-Fernandez J.L., de la Rosa G., Longo N., Navarro J., Munoz-Fernandez M.A., Sanchez-Mateos P., Corbi A.L. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J. Immunol. 2002, 168:2634-2643.
53. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 1998, 188:2175-2180.
54. Ricciardi A., Elia A.R., Cappello P., Puppo M., Vanni C., Fardin P., Eva A., Munroe D., Wu X., Giovarelli M., Varesio L. Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. Mol. Cancer Res. 2008, 6:175-185.
55. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994, 180:83-93.
56. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 1996, 196:137-151.
57. Roy K.C., Bandyopadhyay G., Rakshit S., Ray M., Bandyopadhyay S. IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1a(dim), CD83(+) myeloid dendritic cell subset. J. Cell Sci. 2004, 117:3435-3445.
58. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C.R., Qin S., Lanzavecchia A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998, 28:2760-2769.
59. Sozzani S., Rusnati M., Riboldi E., Mitola S., Presta M. Dendritic cell-endothelial cell cross-talk in angiogenesis. Trends Immunol. 2007, 28:385-392.
60. Steinman R.M. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 2011, 30:1-22.
61. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
62. Steinman R.M., Idoyaga J. Features of the dendritic cell lineage. Immunol. Rev. 2010, 234:5-17.
63. Swetman Andersen C.A., Handley M., Pollara G., Ridley A.J., Katz D.R., Chain B.M. beta1-Integrins determine the dendritic morphology which enhances DC-SIGN-mediated particle capture by dendritic cells. Int. Immunol. 2006, 18:1295-1303.
64. Tkachenko N., Wojas K., Tabarkiewicz J., Rolinski J. Generation of dendritic cells from human peripheral blood monocytes - comparison of different culture media. Folia Histochem. Cytobiol. 2005, 43:25-30.
65. Uchi H., Arrighi J.F., Aubry J.P., Furue M., Hauser C. The sesquiterpene lactone parthenolide inhibits LPS- but not TNF-alpha-induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogen-activated protein kinase pathway. J. Allergy Clin. Immunol. 2002, 110:269-276.
66. Valenick L.V., Hsia H.C., Schwarzbauer J.E. Fibronectin fragmentation promotes alpha4beta1 integrin-mediated contraction of a fibrin-fibronectin provisional matrix. Exp. Cell Res. 2005, 309:48-55.
67. Vicari A.P., Caux C., Trinchieri G. Tumour escape from immune surveillance through dendritic cell inactivation. Semin. Cancer Biol. 2002, 12:33-42.
68. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:2588-2592.
69. Zhu S.N., Chen M., Jongstra-Bilen J., Cybulsky M.I. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med. 2009, 206:2141-2149.
70. Zuo H.J., Lin J.Y., Liu Z.Y., Liu W.F., Liu T., Yang J., Liu Y., Wang D.W., Liu Z.X. Activation of the ERK signaling pathway is involved in CD151-induced angiogenic effects on the formation of CD151-integrin complexes. Acta Pharmacol. Sin. 2010, 31:805-812.